We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
This peptide sequence has residues 438-458 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the N-terminus.
CAT No:S29001
Synonyms/Alias:Biotin - LC - SNNLDSKVGGNYNYLYRLFRK
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
Sequence | One Letter Code: Biotin-LC-SNNLDSKVGGNYNYLYRLFRK Three-Letter Code: Biotin-LC-Ser-Asn-Asn-Leu-Asp-Ser-Lys-Val-Gly-Gly-Asn-Tyr-Asn-Tyr-Leu -Tyr -Arg-Leu-Phe-Arg-Lys-OH |
Purity | 0.95 |
Size | 0.1 mg |
References | 1. Wan Y, Shang J, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020 Mar 17;94(7). 2. Chen Y, et al. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020 Feb 17. |
Required fields are marked with *
×Required fields are marked with *
×If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com